Koers Acro Biomedical Co., Ltd. Other OTC
Aandelen
ACBM
US0048921052
Voedselverwerking
Omzet 2021 | 1,2 mln. 1,12 mln. | Omzet 2022 | 658K 617K | Marktkapitalisatie | 270 mln. 253 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | -7 mln. -6,55 mln. | Nettowinst (verlies) 2022 | -15 mln. -14,04 mln. | EV/omzet 2021 | 233 x |
Nettoliquiditeiten 2021 | 24,08K 22,54K | Nettoschuld 2022 | 98,69K 92,4K | EV/omzet 2022 | 410 x |
K/w-verhouding 2021 |
-32,5
x | K/w-verhouding 2022 |
-17
x | Werknemers | - |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 50,03% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Shi Ming Li
CTO | Chief Tech/Sci/R&D Officer | - | - |
Jer Li Lin
CTO | Chief Tech/Sci/R&D Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Pao Chi Chu
CEO | Chief Executive Officer | 70 | 30-01-17 |
Cheng Hsiang Kao
PRN | Corporate Officer/Principal | - | - |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+13,21% | 8,01 mld. | |
+1,64% | 7,36 mld. | |
+12,30% | 6,54 mld. | |
-6,99% | 3,73 mld. | |
-6,82% | 3,42 mld. | |
-4,78% | 1,24 mld. | |
+12,61% | 935 mln. | |
-41,81% | 886 mln. | |
-21,53% | 827 mln. |